drugset / Trial / NCT04345276

Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

NCT04345276

NaSingle-groupOpen-labelTreatment

Summary

Evaluation of the efficacy and safety of Danoprevir sodium tablet combined with ritonavir for SARS-CoV-2 infected patients.

Timeline

Start
2020-03-18
Primary completion
2020-04-15
Completion
2020-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject danoprevir Small molecule 100 mg Oral
Background Ritonavir Other / unclassified 100 mg

Indications